These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38313160)

  • 1. Sex-Related Differences in Self-Reported Symptoms at Diagnosis in Pheochromocytomas and Paragangliomas.
    Parisien-La Salle S; Bourdeau I
    J Endocr Soc; 2024 Jan; 8(3):bvae005. PubMed ID: 38313160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative Recurrences in Patients Operated for Pheochromocytomas and Paragangliomas: New Data Supporting Lifelong Surveillance.
    Parisien-La Salle S; Chbat J; Lacroix A; Perrotte P; Karakiewicz P; Saliba I; Le XK; Olney HJ; Bourdeau I
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromogranin A in a Cohort of Pheochromocytomas and Paragangliomas: Usefulness at Diagnosis and as an Early Biomarker of Recurrence.
    Parisien-La Salle S; Provençal M; Bourdeau I
    Endocr Pract; 2021 Apr; 27(4):318-325. PubMed ID: 33581325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical Expression of Choline Acetyltransferase and Catecholamine-Synthesizing Enzymes in Head-and-Neck and Thoracoabdominal Paragangliomas and Pheochromocytomas.
    Kimura N; Shiga K; Kaneko KI; Oki Y; Sugisawa C; Saito J; Tawara S; Akahori H; Sogabe S; Yamashita T; Takekoshi K; Naruse M; Katabami T
    Endocr Pathol; 2021 Dec; 32(4):442-451. PubMed ID: 34743284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Biomarkers of Metastasizing Paragangliomas and Pheochromocytomas.
    Snezhkina A; Pavlov V; Dmitriev A; Melnikova N; Kudryavtseva A
    Life (Basel); 2021 Nov; 11(11):. PubMed ID: 34833055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.
    Rao D; Peitzsch M; Prejbisz A; Hanus K; Fassnacht M; Beuschlein F; Brugger C; Fliedner S; Langton K; Pamporaki C; Gudziol V; Stell A; Januszewicz A; Timmers HJLM; Lenders JWM; Eisenhofer G
    Eur J Endocrinol; 2017 Aug; 177(2):103-113. PubMed ID: 28476870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Pediatric vs Adult Pheochromocytomas and Paragangliomas.
    Pamporaki C; Hamplova B; Peitzsch M; Prejbisz A; Beuschlein F; Timmers HJLM; Fassnacht M; Klink B; Lodish M; Stratakis CA; Huebner A; Fliedner S; Robledo M; Sinnott RO; Januszewicz A; Pacak K; Eisenhofer G
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1122-1132. PubMed ID: 28324046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paraganglioma.
    Pamporaki C; Prodanov T; Meuter L; Berends AMA; Bechmann N; Constantinescu G; Beuschlein F; Remde H; Januszewicz A; Kerstens MN; Timmers HJLM; Taïeb D; Robledo M; Lenders JWM; Pacak K; Eisenhofer G
    Eur J Cancer; 2022 Jul; 169():32-41. PubMed ID: 35500459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of Alpha-inhibin Expression in Pheochromocytomas and Paragangliomas.
    Mete O; Pakbaz S; Lerario AM; Giordano TJ; Asa SL
    Am J Surg Pathol; 2021 Sep; 45(9):1264-1273. PubMed ID: 33826547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical differences between small and large pheochromocytomas and paragangliomas.
    Zhao L; Li Z; Meng X; Fan H; Zhang Z; Zhang Z; Liu Y; Zhou X; Zhu H
    Front Endocrinol (Lausanne); 2023; 14():1087506. PubMed ID: 36967797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Characteristics of Incidental Pheochromocytoma and Paraganglioma.
    Zhang J; Li M; Pang Y; Wang C; Wu J; Cheng Z; Li X; Lu Z; Liu Y; Guo J; Chen X; He Y; Guan X; Xu X; Wang Y; Liu J; Guo W; Hou Y; Liu L; Jiang J; Gao X
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e1835-e1842. PubMed ID: 35106577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Genetics, and Therapeutic Approaches.
    Kuo MJM; Nazari MA; Jha A; Pacak K
    Front Endocrinol (Lausanne); 2022; 13():936178. PubMed ID: 35903274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel liquid biopsy (NETest) identifies paragangliomas and pheochromocytomas with high accuracy.
    Pacak K; Kidd M; Meuter L; Modlin IM
    Endocr Relat Cancer; 2021 Oct; 28(11):731-744. PubMed ID: 34515661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disentangling of Malignancy from Benign Pheochromocytomas/Paragangliomas.
    Kim KY; Kim JH; Hong AR; Seong MW; Lee KE; Kim SJ; Kim SW; Shin CS; Kim SY
    PLoS One; 2016; 11(12):e0168413. PubMed ID: 27992508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic spectrum in a Canadian cohort of apparently sporadic pheochromocytomas and paragangliomas: New data on multigene panel retesting over time.
    Parisien-La Salle S; Dumas N; Bédard K; Jolin J; Moramarco J; Lacroix A; Lévesque I; Burnichon N; Gimenez-Roqueplo AP; Bourdeau I
    Clin Endocrinol (Oxf); 2022 Jun; 96(6):803-811. PubMed ID: 34750850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pheochromocytomas and Abdominal Paragangliomas: A Practical Guidance.
    Calissendorff J; Juhlin CC; Bancos I; Falhammar H
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases.
    Archier A; Varoquaux A; Garrigue P; Montava M; Guerin C; Gabriel S; Beschmout E; Morange I; Fakhry N; Castinetti F; Sebag F; Barlier A; Loundou A; Guillet B; Pacak K; Taïeb D
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1248-57. PubMed ID: 26637204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pheochromocytoma and paraganglioma: clinical feature-based disease probability in relation to catecholamine biochemistry and reason for disease suspicion.
    Geroula A; Deutschbein T; Langton K; Masjkur J; Pamporaki C; Peitzsch M; Fliedner S; Timmers HJLM; Bornstein SR; Beuschlein F; Stell A; Januszewicz A; Prejbisz A; Fassnacht M; Lenders JWM; Eisenhofer G
    Eur J Endocrinol; 2019 Oct; 181(4):409-420. PubMed ID: 31370000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical characteristics of patients with normotension in pheochromocytomas and paragangliomas.
    Zhao L; Zhang T; Meng X; Fan H; Zhang Z; Liu Y; Zhou X; Zhu H
    Endocrine; 2023 Apr; 80(1):174-182. PubMed ID: 36749542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High specificity of spot urinary free metanephrines in diagnosis and prognosis of pheochromocytomas and paragangliomas by HPLC with electrochemical detection.
    Zuo M; Zhen Q; Zhang X; Zou W; Yang X; Tian G; Shi Z; Li Q; Ding M
    Clin Chim Acta; 2018 Mar; 478():82-89. PubMed ID: 29273559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.